Aplion Medical Corporation
Aplion Medical Corporation is focused on meeting the needs of patients with chronic hard to heal wounds and supporting those professionals that provide them with care. This includes clinicians and health services providers in settings like homecare, extended care, hospitals, clinics, as well as physician offices. The goal is the improved treatment of these patients employing “active” wound care therapy.
To this end we strive to make innovative, safe, and effective products that contribute to the improved treatment and healing of these difficult wounds. We work to have the greatest reliability and quality in our products. We aim to serve the providers , clinicians, and patients who battle with these wounds daily.
Aplion – Intermountain Healthcare Corporation Partnership
In support of this effort Intermountain Healthcare Corporation, a premier provider of health care services in the Mountain West has made an investment in Aplion Medical. After having performed the first clinical study of the Acton Topical Delivery System, Intermountain Healthcare felt there was significant potential for the device and has invested in the further development and delivery of the product to the health care community.
Advisors
Dr. Robert Kirsner
Advisor
Dr. Robert Kirsner is a Tenured Professor, Interim Chairman and holds the endowed Harvey Blank Chair in Dermatology in the Department of Dermatology and Cutaneous Surgery at the University of Miami Miller School of Medicine. He currently serves as director of the University of Miami Hospital Wound Center and Chief of Dermatology at the University of Miami Hospital.
Dr. Kirsner received his undergraduate degree from Texas A&M University (1984) and received his medical degree from the University of Miami (1988) and he completed his doctorate in Epidemiology from the University of Miami (2004). Dr. Kirsner serves on the editorial boards for a number of journals in Dermatology and Wound Healing. He recently completed his term as chair of the American Academy of Dermatology’s Council on Education and as Board member of the Wound Healing Society. He is a trustee for the Dermatology Foundation and past president of the Association for the Advancement of Wound Care and the Florida Society of Dermatology and Dermatologic Surgery. In addition industry sponsored funding, he is a recipient of NIH, ACS, CDC funding for his research. Independent of books, book chapters and abstracts, he has published over 400 articles.
Dr. William Tettelbach
Advisor
Currently Dr. William Tettelbach serves as the system-wide Medical Director of Wound & Skin Care for Intermountain Healthcare, as well as Program Director of the Undersea & Hyperbaric Medicine Fellowship in Salt Lake City for Duke University School of Medicine. He also has served as an active member of the Intermountain Healthcare Infection Control Guidance Council and has been involved in the development of institutional policies that have resulted in a system-wide reduction in central line associated blood stream infections and the creation of an antimicrobial stewardship program. Under his medical directorship the Intermountain Centers for Comprehensive Wound Care have continued to expand their outreach while positively impacting patient outcomes and increasing collaboration across multiple specialties.
Dr. Tettelbach, MD, FACP, FIDSA, CWS earned his medical degree from The University of Tennessee School of Medicine. He completed his Internal Medicine residency and Infectious Diseases fellowship, as well as received formal training in Biomedical Informatics at the University of Utah. He currently holds boards in Infectious Diseases, Internal Medicine, Undersea & Hyperbaric Medicine and retains an academic appointment at Duke University School of Medicine.
He served as Medical Director for TheraDoc and provided infectious diseases guidance for the development of integrated clinical surveillance/decision support software modules that are now utilized in over 600 hospitals across the nation.
Previously Dr. Tettelbach also led the development of a Cerner rules based electronic sepsis alert module, also known as the “St. John Sepsis Agent”. This module has been has been adopted by several healthcare systems such as Toronto East General Hospital in Canada, the Henry Ford Medical Center in Detroit, Michigan, the University of Alabama at Birmingham Health Center and Catholic Healthcare West in California.
Dr. Marc Robins
Advisor
Marc S. Robins, Doctor of Osteopathic Medicine is the Medical Director, Hyperbaric Medicine at Utah Valley Regional Medical Center since 2008.
Dr. Robins attended Western University of Health Sciences, Pomona, CA and completed his residency at David Grant USAF Regional Medical Center, Travis AFB, CA . Dr Robins became Board Certified in Family Medicine 1991 and obtained a Masters in Public Health at Harvard School of Public Health, Boston, MA 1998 .
He also completed a residency at USAF School of Aerospace Medicine, Brooks AFB, TX 1998 – 2000 and became
Board Certified in Aerospace Medicine and Occupational Medicine
Dr Robins holds a Subspecialty Board Certification for Hyperbaric Medicine. He also practiced ER Medicine for 9 years and 20 years as Flight Surgeon/Aerospace Medicine Specialist for the USAF and holds the rank of Colonel (retired).